blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2772267

EP2772267 - Immunogenic compositions and methods [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.03.2017
Database last updated on 24.04.2024
Most recent event   Tooltip05.10.2018Lapse of the patent in a contracting state
New state(s): TR
published on 07.11.2018  [2018/45]
Applicant(s)For all designated states
Longhorn Vaccines and Diagnostics, LLC
2 Bethesda Metro Center, Suite 910
Bethesda, MD 20814 / US
[2015/01]
Former [2014/36]For all designated states
Longhorn Vaccines & Diagnostics, LLC
2 Bethesda Metro Center, Suite 910
Bethesda, MD 20814 / US
Inventor(s)01 / Fischer, Gerald W.
6417 Lybrook Drive
Bethesda, MD 20817 / US
02 / Daum, Luke T.
318 Startwood Drive
San Antonio, TX 78209 / US
 [2014/36]
Representative(s)Bond, Christopher William
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
[N/P]
Former [2014/36]Bond, Christopher William
Forresters
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Application number, filing date14166377.327.08.2008
[2014/36]
Priority number, dateUS20070968145P27.08.2007         Original published format: US 968145 P
[2014/36]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2772267
Date:03.09.2014
Language:EN
[2014/36]
Type: A3 Search report 
No.:EP2772267
Date:10.12.2014
Language:EN
[2014/50]
Type: B1 Patent specification 
No.:EP2772267
Date:27.04.2016
Language:EN
[2016/17]
Search report(s)(Supplementary) European search report - dispatched on:EP10.11.2014
ClassificationIPC:A61K39/09, A61K39/145, A61K39/085, A61K39/12, A61K39/102, C07K14/005
[2015/42]
CPC:
C07K14/005 (EP,US); A61K39/085 (EP,US); A61K39/092 (EP,US);
A61K39/102 (EP,US); A61K39/12 (EP,US); A61K39/145 (EP,US);
A61P31/04 (EP); A61P31/12 (EP); A61P31/16 (EP);
A61P37/00 (EP); C07K14/33 (US); C07K14/35 (EP,US);
C07K7/06 (US); C12N7/00 (EP,US); A61K2039/525 (EP,US);
A61K2039/5252 (EP,US); A61K2039/5254 (EP,US); A61K2039/543 (EP,US);
A61K2039/545 (EP,US); A61K2039/55566 (EP,US); A61K2039/575 (US);
A61K2039/6037 (EP,US); A61K2039/6043 (EP,US); A61K2039/6068 (EP,US);
A61K2039/70 (EP,US); C07K2319/40 (EP,US); C07K2319/42 (EP,US);
C12N2760/16122 (EP,US); C12N2760/16134 (EP,US); C12N2760/16161 (EP,US) (-)
Former IPC [2014/36]A61K39/295, A61K39/145, A61K39/085, A61K39/116, A61K39/102, A61P31/16, A61P31/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/17]
Former [2014/36]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Immunogene Zusammensetzungen und Verfahren[2014/36]
English:Immunogenic compositions and methods[2014/36]
French:Compositions immunogènes et procédés[2014/36]
Examination procedure13.01.2015Amendment by applicant (claims and/or description)
13.01.2015Examination requested  [2015/09]
29.01.2016Communication of intention to grant the patent
02.03.2016Fee for grant paid
02.03.2016Fee for publishing/printing paid
02.03.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP08828704.0  / EP2185196
Divisional application(s)EP16158089.9  / EP3058954
Opposition(s)30.01.2017No opposition filed within time limit [2017/14]
Fees paidRenewal fee
29.04.2014Renewal fee patent year 03
29.04.2014Renewal fee patent year 04
29.04.2014Renewal fee patent year 05
29.04.2014Renewal fee patent year 06
23.07.2014Renewal fee patent year 07
03.06.2015Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.08.2008
AT27.04.2016
BG27.04.2016
CY27.04.2016
CZ27.04.2016
DK27.04.2016
EE27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
IS27.04.2016
IT27.04.2016
LT27.04.2016
LV27.04.2016
MC27.04.2016
NL27.04.2016
PL27.04.2016
RO27.04.2016
SI27.04.2016
SK27.04.2016
TR27.04.2016
NO27.07.2016
GR28.07.2016
LU27.08.2016
PT29.08.2016
MT31.08.2016
[2018/45]
Former [2018/38]HU27.08.2008
AT27.04.2016
BG27.04.2016
CY27.04.2016
CZ27.04.2016
DK27.04.2016
EE27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
IS27.04.2016
IT27.04.2016
LT27.04.2016
LV27.04.2016
MC27.04.2016
NL27.04.2016
PL27.04.2016
RO27.04.2016
SI27.04.2016
SK27.04.2016
NO27.07.2016
GR28.07.2016
LU27.08.2016
PT29.08.2016
MT31.08.2016
Former [2018/33]HU27.08.2008
AT27.04.2016
CY27.04.2016
CZ27.04.2016
DK27.04.2016
EE27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
IS27.04.2016
IT27.04.2016
LT27.04.2016
LV27.04.2016
MC27.04.2016
NL27.04.2016
PL27.04.2016
RO27.04.2016
SI27.04.2016
SK27.04.2016
NO27.07.2016
GR28.07.2016
LU27.08.2016
PT29.08.2016
MT31.08.2016
Former [2018/30]HU27.08.2008
AT27.04.2016
CY27.04.2016
CZ27.04.2016
DK27.04.2016
EE27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
IS27.04.2016
IT27.04.2016
LT27.04.2016
LV27.04.2016
MC27.04.2016
NL27.04.2016
PL27.04.2016
RO27.04.2016
SI27.04.2016
SK27.04.2016
NO27.07.2016
GR28.07.2016
LU27.08.2016
PT29.08.2016
Former [2017/37]AT27.04.2016
CZ27.04.2016
DK27.04.2016
EE27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
IT27.04.2016
LT27.04.2016
LV27.04.2016
MC27.04.2016
NL27.04.2016
PL27.04.2016
RO27.04.2016
SI27.04.2016
SK27.04.2016
NO27.07.2016
GR28.07.2016
LU27.08.2016
PT29.08.2016
Former [2017/23]AT27.04.2016
CZ27.04.2016
DK27.04.2016
EE27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
IT27.04.2016
LT27.04.2016
LV27.04.2016
MC27.04.2016
NL27.04.2016
PL27.04.2016
RO27.04.2016
SI27.04.2016
SK27.04.2016
NO27.07.2016
GR28.07.2016
PT29.08.2016
Former [2017/10]AT27.04.2016
CZ27.04.2016
DK27.04.2016
EE27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
IT27.04.2016
LT27.04.2016
LV27.04.2016
NL27.04.2016
PL27.04.2016
RO27.04.2016
SK27.04.2016
NO27.07.2016
GR28.07.2016
PT29.08.2016
Former [2017/09]AT27.04.2016
CZ27.04.2016
DK27.04.2016
EE27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
IT27.04.2016
LT27.04.2016
LV27.04.2016
NL27.04.2016
PL27.04.2016
RO27.04.2016
NO27.07.2016
GR28.07.2016
PT29.08.2016
Former [2017/07]AT27.04.2016
DK27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
IT27.04.2016
LT27.04.2016
LV27.04.2016
NL27.04.2016
PL27.04.2016
NO27.07.2016
GR28.07.2016
PT29.08.2016
Former [2017/04]AT27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
IT27.04.2016
LT27.04.2016
LV27.04.2016
NL27.04.2016
PL27.04.2016
NO27.07.2016
GR28.07.2016
PT29.08.2016
Former [2016/51]AT27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
LT27.04.2016
LV27.04.2016
NL27.04.2016
PL27.04.2016
NO27.07.2016
GR28.07.2016
PT29.08.2016
Former [2016/50]AT27.04.2016
ES27.04.2016
FI27.04.2016
HR27.04.2016
LT27.04.2016
LV27.04.2016
NL27.04.2016
PL27.04.2016
NO27.07.2016
Former [2016/49]FI27.04.2016
LT27.04.2016
NL27.04.2016
PL27.04.2016
NO27.07.2016
Former [2016/46]LT27.04.2016
NL27.04.2016
NO27.07.2016
Former [2016/44]NL27.04.2016
Documents cited:Search[X]WO2007051036  (PROTELIX INC [US], et al) [X] 1-15 * p. 7-26; examples; p. 24, l. 5-12; p. 26, l. 13-19; p. 30, l. 13-14; claims *;
 [A]WO2007056266  (SIDNEY KIMMEL CANCER CT [US], et al) [A] 1-15 * 0020-0025; 0035; 0041-0045; 0058-0066; 0071-0072; 0079; 0084; 0086-0091; 0097-0133; 0160; 0205-0250; claims *;
 [AD]  - DANILA VALMORI ET AL, "Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination", JOURNAL OF IMMUNOLOGY, AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (19920715), vol. 149, no. 2, ISSN 0022-1767, pages 717 - 721, XP002173089 [AD] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.4049/jimmunol.149.2.717
by applicantUS4196265
 US4356170
 US4372945
 US4474757
 US4554101
 US4596792
 US4599231
 US4599230
 US4601903
 US4608251
 US4634664
 US4634666
 US4668476
 US4746490
 US4816513
 US5145684
 US5182109
 US5186898
 US5399363
 WO9508348
 US5482856
 US5503841
 US5543158
 US5552157
 US5565213
 US5567434
 US5641515
 US5656016
 US5679356
 US5697899
 US5738868
 US5741516
 US5770219
 US5779708
 US5783208
 US5785975
 US5795582
 US5795587
 US5797898
 US5800810
 US6033673
 US6060068
 US6306404
 US6440423
 US6451325
 US6500432
 US6534065
 US6572866
 WO03053462
 US6603998
 US6713068
 WO2004043407
 US6759241
 US6780421
 US6793928
 US2004223976
 US2005169941
 US7090853
 US7223409
 US2008032921
 US2008069821
 US2008075708
 US7357936
 US2008107687
 US2008107665
 US2008118531
 US2008145373
 US2008181914
 US2008181905
    - ARTHUR OSOL AND JOHN E. HOOVER, Remington's Pharmaceutical Sciences 15th Edition, MACK PUBLISHING CO.,, pages 1032-35 - 1570-80
    - Antibodies: A Laboratory Manual, COLD SPRING HARBOR PRESS
    - STITES ET AL., Basic and Clinical Immunology(4th ed.), MEDICAL PUBLICATIONS
    - ALTSCHUL ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410
    - CONLEY ET AL., VACCINE, (1994), vol. 12, pages 445 - 451
    - FENG; DOOLITTLE, J. MOL. EVOL., (1987), vol. 35, pages 351 - 360
    - HENIKOFF; HENIKOFF, PROC. NATL. ACAD. SCI. USA, (1989), vol. 89, page 10915
    - HIGGINS; SHARP, COMPUT. APPL. BIOSCI., (1989), vol. 5, pages 151 - 153
    - KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 5873 - 5787
    - KOHLER; MILSTEIN, NATURE, (1975), vol. 256, pages 495 - 497
    - LOU, M., NATURE, (200609), vol. 443, pages 37 - 38
    - NEEDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, page 443
    - PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, page 2444
    - SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, page 482
    - TOLMAN ET AL., INT. J. PEP. PROTO RES., (1993), vol. 41, pages 455 - 466
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.